fda food and drug administration

FDA red food dye ban

FDA announces ban on red dye No. 3. Here's what to expect — and why some families already avoid the food coloring.

The Food and Drug Administration announced on Jan. 15 that it is revoking authorization of the food dye known as red dye No. 3. The agency had been reviewing a petition to ban the petroleum-based colorant since 2022,

FOX News on MSN · 20h

FDA bans red food dye due to potential cancer risk

The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary supplements and ingested medicines, as reported on Wednesday.

USA Today · 20h

FDA bans Red No. 3 in food and ingested drugs. Here's when it has to be phased out by

Red No. 3, also known as erythrosine, is a color additive made from petroleum that gives foods and drinks a bright, cherry-red color.

FDA proposes mandatory nutrition labels on front of packages

UPI News on MSN · 1d

New FDA proposal would put 'front-of-package' nutrition labels on food products

The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced.

U.S. News & World Report · 22h

FDA Proposes New Front-of-Package Food Labels

The U.S. Food and Drug Administration (FDA) has proposed a new rule requiring bold, easy-to-read nutrition labels on the front of food and beverage packages. These labels, which would highlight content of sugar,

USA TODAY on MSN · 1d

FDA wants food companies to put nutrition labels on the front of packaging. Why?

The labels will also include new information about the product's level of saturated fat, sodium and added sugars, categorizing them as “low,” “medium,” or “high.”Start the day smarter. Get all the news you need in your inbox each morning.

MLive1m

Common cookware may contaminate food, FDA warns

The U.S. Food & Drug Administration (FDA) would like for people to be aware of the potential risks of using common cooking ...

JD Supra1d

FDA’s evolving regulatory framework for AI use in drug & device clinical trials and research

Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of AI in medical product development, ...

STAT5d

Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency

Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

Federal judge blocks FDA from enforcing graphic cigarette label rule

A federal judge in Texas has temporarily blocked the Food and Drug Administration (FDA) from enforcing a requirement that ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results